Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
US Department of Justice
McKesson
Daiichi Sankyo
Federal Trade Commission
McKinsey
Mallinckrodt
Colorcon
Boehringer Ingelheim

Generated: September 20, 2018

DrugPatentWatch Database Preview

VAZCULEP Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Vazculep, and when can generic versions of Vazculep launch?

Vazculep is a drug marketed by Avadel Legacy and is included in one NDA.

The generic ingredient in VAZCULEP is phenylephrine hydrochloride. There are twenty-one drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the phenylephrine hydrochloride profile page.

Drug patent expirations by year for VAZCULEP
Pharmacology for VAZCULEP
Synonyms for VAZCULEP
(-)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol, hydroc hloride
(-)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol, hydrochloride
(-)-alpha-Hydroxy-beta-(methylamino)ethyl-alpha-(3-hydroxybenzene) hydrochloride
(-)-m-Hydroxy-alpha-((methylamino)methyl)benzyl alcohol hydrochloride
(-)-Phenylephrine hydrochloride
(R)-(-)-1-(3-Hydroxyphenyl)-2-methylaminoethanol hydrochloride
(R)-(-)-3-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol hydrochloride
(R)-(-)-Phenylephrine (hydrochloride)
(R)-(-)-Phenylephrine hydrochloride
(R)-(-)-Phenylephrine hydrochloride, analytical standard
(R)-(-)-Phenylephrine hydrochloride, powder
(R)-(-)-Phenylephrine hydrochloride, tested according to Ph.Eur.
(R)-3-(1-Hydroxy-2-(methylamino)ethyl)phenol hydrochloride
(R)-3-hydroxy-a-[(methylamino)methyl]-benzenemethanol hydrochloride
(R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol hydrochloride
(R)-Phenylephrine hydrochloride
04JA59TNSJ
1-m-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol hydrochloride
10% phenylephrine HCl cream, Solvay/SLA Pharma
20% phenylephrine HCl cream, Solvay/SLA Pharma
3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol hydrochloride
3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride
3-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol hydrochloride
50741-76-9
59-42-7 (Parent)
61-76-7
644-22-4
827-62-3
AB2000665
AC1NR4GJ
Adrianol
Afrin 4 Hour Nasal Spray
AK150851
AKOS022190146
Alcon-efrin
Almefrin
BCP0726000237
Benzedrex Nasal Spray, Regular
Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, hydrochloride (1:1), (alphaR)-
Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, hydrochloride (R)-
Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, hydrochloride, (-)-
Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, hydrochloride, (alphaR)-
Benzyl alcohol, m-hydroxy-alpha-((methylamino)methyl)-, hydrochloride, (-)-
Biomydrin
C9H13NO2.HCl
CAS-61-76-7
CCG-39113
CCRIS 219
CHEBI:8094
CHEMBL1200339
Consdrin
Consdrin hydrochloride
CS-2585
D-(-)-Phenylephrine hydrochloride
D00511
D0D7QO
DSSTox_CID_1142
DSSTox_GSID_21142
DSSTox_RID_75972
DTXSID3021142
Efricel
EINECS 200-517-3
Emagrin
EU-0100920
Fenilfar
Fenox
GL9617
Histabid
HMS1920H08
HY-B0471
Idrianol
Incostop
Isophrin hydrochloride
l-1-(m-Hydroxyphenyl)-2-methyl-aminoethanol hydrochloride
L-Pheny lephrine Hydrochloride
L-PHENYLEPHRINE HYDROCHLORIDE
Levophenylephrine hydrochloride
Lexatol
LP00920
LS-1454
m-Methylaminoethanolphenol hydrochloride
meta-Sympatol
meta-Synephrine hydrochloride
Metaoxedrine chloride
Metaoxedrine hydrochloride
MFCD00012605
MLS000069696
MLS006012005
MolPort-003-666-260
Mydfrin
NCGC00024257-04
NCGC00024257-08
NCGC00094231-01
NCGC00256496-01
NCGC00258813-01
NCGC00261605-01
NCI-C55641
Neo-Synephrine (TN)
Neo-Synesin 1
Neooxedrine chloride
Neophryn
Neosympatol
Neosynephrine hydrochloride
neosynephrine hydrocholride
NSC-757273
NSC757273
OCYSGIYOVXAGKQ-FVGYRXGTSA-N
Oftalfrine
OP-Isophrin
Op-Isophrin-Z
Opera_ID_1786
P 6126
P0398
Pharmakon1600-01500483
Phenistan
Phenylephrine HCl
PHENYLEPHRINE HYDROCHLORIDE
Phenylephrine hydrochloride (JP17/USP)
Phenylephrine hydrochloride [USAN:JAN]
Phenylephrine hydrochloride [USP:JAN]
Phenylephrine hydrochloride for peak identification, European Pharmacopoeia (EP) Reference Standard
Phenylephrine hydrochloride gel
Phenylephrine hydrochloride gel (fecal incontinence)
Phenylephrine hydrochloride gel (fecal incontinence), SLA Pharma/Ventrus Biosciences
Phenylephrine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Phenylephrine hydrochloride, l-
Phenylephrine Hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur and BP
Phenylephrine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Phenylephrine.HCl
Phenylephrinehydrochloride
Prefrin
PubChem23988
Pyristan
Q-201561
R-(-)-m-Synephrine hydrochloride
Relief
Rhinall
s2569
SCHEMBL24654
SMR000058497
SPECTRUM1500483
SR-01000075286
SR-01000075286-1
ST24035423
Stanephrin
Sucraphen
Sudafed PE
Synasal
Synethenate
Tox21_110897
Tox21_110897_1
Tox21_201261
Tox21_302846
Tox21_500920
UNII-04JA59TNSJ
UNII-O2VT86KV7E component OCYSGIYOVXAGKQ-FVGYRXGTSA-N
Vasosulf
VEN-308
Vicks Sinex Nasal Spray
Vicks Sinex Vapospray
VU0239753-6

US Patents and Regulatory Information for VAZCULEP

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avadel Legacy VAZCULEP phenylephrine hydrochloride SOLUTION;INTRAVENOUS 204300-001 Jun 27, 2014 AP RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Avadel Legacy VAZCULEP phenylephrine hydrochloride SOLUTION;INTRAVENOUS 204300-002 Jun 27, 2014 AP RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Avadel Legacy VAZCULEP phenylephrine hydrochloride SOLUTION;INTRAVENOUS 204300-003 Jun 27, 2014 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
US Department of Justice
McKesson
Daiichi Sankyo
Federal Trade Commission
McKinsey
Mallinckrodt
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.